IP Library Granted Patent US 12,281,074
Granted Patent B2
US 12,281,074 · App. 18/390,624 · Granted Apr 22, 2025

Method for producing amino acid derivatives

Inventors: Masato Murai (Tokyo, JP); Jun Takehara (Tokyo, JP); Daiki Okado (Tokyo, JP)
Assignee: UBE CORPORATION
C07D211/60
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,281,074
App. No.
18/390,624
Granted
Apr 22, 2025
Kind
B2
Abstract

The present invention aims to provide a method for producing a (2S,5R)-5-(protected oxyamino)-piperidine-2-carboxylic acid derivative at a low cost that can be performed under mild reaction conditions not requiring a facility at an extremely low temperature, is safer, can control the quality of the desired product with ease, and shows good workability in the site of production. A method for producing a compound represented by the formula (2): wherein PG 1 is an amino-protecting group, PG 2 is an amino-protecting group, PG 3 is a hydroxyl-protecting group, LG is a leaving group, and R is a hydrocarbon group having 1-8 carbon atoms and optionally having substituent(s), including a step of reacting a compound represented by the formula (1): wherein each symbol is as defined above, with a hydroxylamine derivative represented by the formula PG 2 NHOPG 3 wherein each symbol is as defined above, in the presence of a base in a solvent.

Claims (24)

1. A compound represented by any one of the following formula (2a), (2b), (3b) or (5a):

wherein Boc is a tert-butoxycarbonyl group, Ac is an acetyl group, Ns is a p-nitrobenzenesulfonyl group, and Bn is a benzyl group.

2. A method for producing a compound represented by the formula (4):

wherein R is a hydrocarbon group having 1-8 carbon atoms and optionally having one or more substituents, and PG 3 is a hydroxyl-protecting group,

or a salt thereof, comprising

reacting a compound represented by the formula (1):

wherein PG 1 is an amino-protecting group, LG is a sulfonyloxy group, and R is as defined above,

with a hydroxylamine derivative represented by the formula PG 2 NHOPG 3 , wherein PG 2 is an amino-protecting group and PG 3 is as defined above, in the presence of a base in a solvent to obtain a compound represented by the formula (2):

wherein each symbol is as defined above;

removing PG 2 from the aforementioned compound represented by the formula (2) to obtain a compound represented by the formula (3):

wherein each symbol is as defined above,

or a salt thereof; and

removing PG 1 from the aforementioned compound represented by the formula (3).

3. A method for producing a compound represented by the formula (4):

wherein R is a hydrocarbon group having 1-8 carbon atoms and optionally

having one or more substituents, and PG 3 is a hydroxyl-protecting group, or a salt thereof, comprising

reacting a compound represented by the formula (1):

wherein PG 1 is an amino-protecting group, LG is a sulfonyloxy group, and R is as defined above,

with a hydroxylamine derivative represented by the formula PG 2 NHOPG 3 , wherein PG 2 is an amino-protecting group and PG 3 is as defined above, in the presence of a base in a solvent to obtain a compound represented by the formula (2):

wherein each symbol is as defined above;

removing PG 1 from the aforementioned compound represented by the formula (2) to obtain a compound represented by the formula (5):

wherein each symbol is as defined above,

or a salt thereof; and

removing PG 2 from the aforementioned compound represented by the formula (5) to obtain the compound represented by the formula (4).

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVEYANCE PREVIOUSLY RECORDED ON REEL 70201 FRAME 937. ASSIGNOR(S) HEREBY CONFIRMS THE MERGER. Recorded Mar 19, 2025
From: API CORPORATION
To: UBE CORPORATION
Reel/Frame 070565/0659 →
CHANGE OF NAME Recorded Feb 12, 2025
From: API CORPORATION
To: UBE CORPORATION
Reel/Frame 070201/0937 →
Priority Claims (1)
JP 2018-177774 · Sep 21, 2018 · national
Continuity (2)
Division 17277456
Related Publication 20240150292A1 · May 9, 2024
References Cited (39)
US 9120795B2 · Hwang et al. · 2015 [cited by applicant]
US 11897844B2 · Murai · 2024 [cited by examiner]
US 20110294777A1 · Blizzard et al. · 2011 [cited by applicant]
US 20120053350A1 · Mangion et al. · 2012 [cited by applicant]
US 20130274475A1 · Mangion et al. · 2013 [cited by applicant]
US 20140275001A1 · Hwang · 2014 [cited by examiner]
US 20150031659A1 · Gu · 2015 [cited by applicant]
US 20150038478A1 · Gu · 2015 [cited by applicant]
US 20150141401A1 · Abe et al. · 2015 [cited by applicant]
US 20150239906A1 · Maeda · 2015 [cited by applicant]
US 20160318867A1 · Takehara · 2016 [cited by applicant]
US 20220194941A1 · Chung · 2022 [cited by examiner]
US 20240002340A1 · Murai · 2024 [cited by examiner]
CN 105061425A · 2015 [cited by applicant]
EP 3281942A1 · 2018 [cited by applicant]
WO 2009091856A1 · 2009 [cited by applicant]
WO 2010126820A1 · 2010 [cited by applicant]
WO 2013149121A1 · 2013 [cited by applicant]
WO 2014200786A1 · 2014 [cited by applicant]
WO 2015173779A1 · 2015 [cited by applicant]
WO 2017098425A1 · 2017 [cited by applicant]
WO 2017167218A1 · 2017 [cited by applicant]
WO 2018060926A1 · 2018 [cited by applicant]
WO 2019122438A1 · 2019 [cited by applicant]
Sulsky, R. et al., “Alkylation of N-benzyloxyureas and carbamates,” Tetrahedron Letters, 1989, vol. 30, No. 1, pp. 31-34, ISSN: 0040-4039. [cited by applicant]
Mangion, I. K. et al., “A concise synthesis of a B-lactamase inhibitor,” Organic Letters, 2011, vol. 13, No. 20, pp. 5480-5483, ISSN: 1523-7052. [cited by applicant]
ISR issued in International Patent Application No. PCT/JP2019/037399, Dec. 10, 2019, English translation. [cited by applicant]
Written Opinion issued in Int'l Patent Application No. PCT/JP2019/037399, Dec. 10, 2019, English translation. [cited by applicant]
Supplementary partial EESR issue in EP Patent Application No. 19863035.2, May 13, 2022. [cited by applicant]
Edoo et al. “Synthesis of Avibactam Derivatives and Activity on β-Lactamases and Peptidoglycan Biosynthesis Enzymes of Mycobacteria”, Chemistry—A European Journal, vol. 24, No. 32, 2018, 8081-8086. [cited by applicant]
Reasons for Refusal issued in JP Patent Application No. 2020-549244, Oct. 2, 2023, translation. [cited by applicant]
Lafrance et al., “New Synthetic Route to a Dipeptidyl Peptidase-4 Inhibitor”, Org. Lett. 2011, v. 13, pp. 5480-5483. [cited by applicant]
European Search Opinion in EP 19863035, Aug. 18, 2022. [cited by applicant]
T. Allman et al., Canadian Journal of Chemistry, pp. 716-722 (1982). [cited by applicant]
R. Sanders et al., J.C.S. Dalton, pp. 743-747 (1973). [cited by applicant]
C. Hansch et al., 91 Chemical Reviews, pp. 165-195 (1991). [cited by applicant]
A. Debache et al., 49 Tetrahedron Letters, pp. 6119-6121 (2008). [cited by applicant]
J. March, Advanced Organic Chemistry Reaction, Mechanisms and Structure (1992) pp. 248-272. [cited by applicant]
Office Action issued in EP Patent Application No. 19863035.2, Dec. 1, 2023. [cited by applicant]